Tower Research Capital LLC (Trc) Intellia Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,340 shares of NTLA stock, worth $64,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,340
Previous 41,973
84.9%
Holding current value
$64,224
Previous $939,000
86.16%
% of portfolio
0.0%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding NTLA
# of Institutions
321Shares Held
91.4MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$127 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$97.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$97.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$52.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$50.1 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $770M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...